BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• 

  Deals

  Teva Wraps Up $703M Sale of Global Women’s Health Biz to CVC Capital

  The portfolio includes Ovaleap, Zoely, Seasonique, Colpotrophine, Actonel and additional products.

  February 1, 2018

   · 

  5 min read
• Drug Development

  Panacea Pharma Completes Enrollment in Phase I Study of First-in-Class Cancer Vaccine Therapy in Patients with Persistent Prostate Cancer

  PAN-301-1 is a novel nanoparticle immunotherapy vaccine candidate targeting HAAH also known as ASPH.

  February 1, 2018

   · 

  6 min read
• Business

  TraceLink Expands Leadership Team With New Senior VP of Engineering and New CTO Appointment

  TraceLink today announced two key new senior leadership appointments.

  February 1, 2018

   · 

  5 min read
• Business

  Avecia Announces Opening of Cambridge, MA Office

  Avecia announced today the opening of a new corporate office in Cambridge, MA, to support its operations and corporate development activities, and to be more accessible to clients.

  February 1, 2018

   · 

  1 min read
• Business

  Charles River Laboratories Makes Investments in High-Throughput Screening Infrastructure

  Charles River Laboratories today announced a new agreement which grants Charles River commercial access to AstraZeneca’s (NYSE: AZN) high-throughput screening (HTS) and compound management infrastructure.

  February 1, 2018

   · 

  3 min read
• BioMidwest

  Eccrine Systems Awarded USAF Contract for Monitoring Cognitive Status Using Sweat

  Eccrine Systems, has been awarded a $750,000 SBIR Phase II contract by the United States Air Force, focused on real-time measurement of specific biomarkers in human sweat as an index of cognitive performance.

  February 1, 2018

   · 

  2 min read
• Teva Completes Amendment to Credit Facilities on February 1, 2018

  Teva Pharmaceutical Industries Ltd., today announced amendments to its USD and JPY term loan and revolving credit facilities, providing the company greater flexibility in its financial leverage ratio covenants.

  February 1, 2018

   · 

  7 min read
• Drug Development

  MeiraGTx Receives Rare Pediatric Disease Designation for A002 for the Treatment of Achromatopsia Due to Mutations in the CNGB3 Gene

  A002 previously received orphan drug designation from the FDA and the European Medicines Agency for the treatment of ACHM in 2016.

  February 1, 2018

   · 

  4 min read
• BioMidwest

  Neogen Releases Easiest Dairy Antibiotic Tests

  Neogen that it has released BetaStar Advanced -- the easiest method to test for antibiotics in milk.

  February 1, 2018

   · 

  2 min read
• Zynex Introduces The NeuroMove Device To Its Expanding Sales Force

  Zynex today announced the introduction of the NeuroMove device into its expanding direct sales force in the US market.

  February 1, 2018

   · 

  3 min read